Skip to main content

Research

New
History
Case updates

Calendar
Search
Cases
People & firms
Datasets

Product updates
Coverage
Pricing
Docs
Connect your AI

Sign in Create account

Healthcare & life sciences coverage - ElevenFlo

Healthcare & life sciences coverage

111 articles

Week of March 16, 2026

Envision Healthcare: Dual-Silo Chapter 11 Reorganization

Envision Healthcare's chapter 11 reorganized the AmSurg and EVPS silos separately after KKR's 2018 buyout left the physician staffing group overleveraged amid No Surprises Act pressure, reimbursement cuts, labor inflation, and COVID-era disruption.

Amyris Emerges from Bankruptcy After Consumer Brand Sales

Amyris sold its consumer brands and emerged from Chapter 11 in May 2024, retaining its biotechnology platform under ownership of its secured lenders.

InVivo Therapeutics: Failed Trial, Full Creditor Recovery

InVivo Therapeutics filed chapter 11 in Delaware after its INSPIRE 2.0 spinal cord injury trial failed. The cases used a 363 sale to Globus Medical and a liquidating plan that paid creditors in full before a later equity distribution.

Pioneer Health Systems: Confirmed Subchapter V Plan After Failed Sale

Pioneer Health Systems, operating as Direct Orthopedic Care, filed Subchapter V in Delaware on February 21, 2024. This post covers the confirmed plan, failed post-confirmation sale process, DIP financing shifts, and late-case fee and claims disputes.

South Hills Operations: Dual Sale Tracks and Wage Litigation

South Hills Operations filed chapter 11 in the Western District of Pennsylvania after failed nursing-home sale efforts, labor cost pressure, Medicaid reimbursement strain, and Department of Labor wage litigation. The case moved through dual DIP facilities, separate sales, and a liquidating trust.

LaVie Care Centers: From 140 Facilities to Emergence

LaVie Care Centers filed chapter 11 in the Northern District of Georgia after shrinking from roughly 140 facilities to 43 and carrying legacy liabilities from divested operations. The post covers the contested DIP fight, failed sale process, IRS settlement, and June 2025 emergence under Avardis.

Solar Biotech, Inc.: Pictor Sale and Liquidation Trust

Solar Biotech filed chapter 11 in Delaware on June 23, 2024, ran a section 363 sale that ended with Pictor Biotech's $20 million purchase, and later put a liquidating plan into effect on September 30, 2025. The post tracks the sale, DIP financing, and liquidation-trust status.

Guardian Healthcare: 19 Facilities Sold in Chapter 11 Wind-Down

Guardian Healthcare filed chapter 11 in western Pennsylvania on July 29, 2024, sold or transferred 19 skilled nursing facilities, and remains in a wind-down focused on litigation, settlements, and estate administration.

Biolase: MegaGen Sale and Liquidation Plan

Biolase filed chapter 11 in Delaware to sell its business, with MegaGen winning the auction before the estates moved into a confirmed liquidation plan.

Cold Spring Hills Nursing Home Sold to Receiver for $10 Amid $22.6M Philipson Fraud Suit

Cold Spring Hills filed chapter 11 after a $22.6M AG lawsuit over Philipson ownership and alleged fund diversions. A $10 receivership preserved the 588-bed nursing home while unsecured creditors faced a 2% recovery.

Week of March 9, 2026

Vyaire Medical Funds Chapter 11 With $180M Loan, Sells Units to ZOLL and Trudell

Vyaire filed June 9, 2024 in Delaware, obtained a $180M DIP, sold two business units, and confirmed a liquidation plan in Nov 2024.

Gritstone bio: $21.25M Sale and Hybrid Emergence

Gritstone bio entered chapter 11 after clinical and funding setbacks, sold its main assets for $21.25 million, and confirmed a plan that left a reorganized debtor plus a liquidating trust.

1 2…4 5 6

…